ORUKA THERAPEUTICS INC (ORKA) Stock Earnings & Estimates
NASDAQ:ORKA - US6876041087 - Common Stock
14.51 USD
-0.92 (-5.96%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | ||||||||||||
| EBITDA YoY % growth | -9.68M | -11.44M -18.18% | -16.59M -45.02% | -18.68M -12.60% | -8.1M 56.64% | -5.79M 28.52% | -9.76M -68.57% | -19.319M -97.94% | -10.482M 45.74% | -7.185M 31.45% | -88.096M -1,126.11% | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.69M | -11.46M -18.27% | -16.61M -44.94% | -18.71M -12.64% | -8.12M 56.60% | -5.81M 28.45% | -9.77M -68.16% | -19.335M -97.90% | -10.596M 45.20% | -7.296M 31.14% | -88.123M -1,107.83% | N/A -29.15% | N/A -24.22% | N/A -14.07% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -120.96 71.85% | -54.36 55.06% | N/A | N/A | N/A | N/A | N/A | N/A 37.22% | N/A -16.72% | N/A -4.28% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.61 58.43% | -0.63 -29.48% | -0.62 -56.19% | -0.66 -42.63% | -0.68 -12.86% | -0.70 -10.49% | -0.52 17.39% | -0.56 14.96% | -0.61 10.95% | -0.66 5.27% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -30.027M -1.96% | -33.303M -9.85% | -33.813M -34.79% | -35.496M -24.86% | -37.179M -23.82% | -38.352M -15.16% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.46 | -0.50 | 0.04 | 7.96% |
| Q1 2025 Q2Q % growth | -0.40 | -0.52 | 0.12 | 22.50% |
| Q4 2024 Q2Q % growth | -0.49 | -0.70 | 0.21 | 29.55% |
| Q3 2024 Q2Q % growth | -1.46 -1,360.00% | -0.41 | -1.05 | -256.21% |
| Q2 2020 Q2Q % growth | -8.76 35.96% | -31.58 | 22.82 | 72.26% |
| Q1 2020 Q2Q % growth | -9.96 55.38% | -24.97 | 15.01 | 60.11% |
| Q4 2019 Q2Q % growth | -9.24 | -12.12 | 2.88 | 23.75% |
| Q3 2019 Q2Q % growth | -9.12 | -15.91 | 6.79 | 42.68% |
| Q2 2019 Q2Q % growth | -13.68 | -22.77 | 9.09 | 39.91% |
| Q1 2019 Q2Q % growth | -22.32 | -24.24 | 1.92 | 7.90% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -9.89% | -21.08% | 1.64% | 0.85% |
| Revenue | N/A | N/A | N/A | N/A |